Cleared Special

K173511 - ActiveCare TD-4121 Blood Glucose Monitoring System

K173511 is an FDA 510(k) clearance for ActiveCare TD-4121 Blood Glucose Monito..., manufactured by Taidoc Technology Corporation. The device is a Class 2 Chemistry device with product code NBW cleared through the Special 510(k) pathway after a 241-day FDA review.

K173511 · Taidoc Technology Corporation · Chemistry device
Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
Jul 2018
Decision
241d
Days
Class 2
Risk

K173511 is an FDA 510(k) clearance for the ActiveCare TD-4121 Blood Glucose Monitoring System. Classified as System, Test, Blood Glucose, Over The Counter (product code NBW), Class II - Special Controls.

Submitted by Taidoc Technology Corporation (New Taipei City, TW). The FDA issued a Cleared decision on July 12, 2018 after a review of 241 days - an extended review cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1345 - the FDA in vitro diagnostics and chemistry framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Standard predicate reliance. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

FDA 510(k) Submission Details - K173511

510(k) Number K173511 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 13, 2017
Decision Date July 12, 2018
Days to Decision 241 days
Submission Type Special
Review Panel Chemistry (CH)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
152d slower than avg
Panel avg: 89d · This submission: 241d
Pathway characteristics
Modification to existing cleared device.

NBW Device Classification - Class 2, Special Controls

Product Code NBW System, Test, Blood Glucose, Over The Counter
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1345
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - NBW System, Test, Blood Glucose, Over The Counter

All 513
Devices cleared under the same product code (NBW) and FDA review panel - the closest regulatory comparables to K173511.
Confidence Blood Glucose Monitoring System
K173658 · Applied Biomedical, LLC · Aug 2018
Rightest Blood Glucose Monitoring System Max, Rightest Blood Glucose Monitoring System Max Plus, GE Blood Glucose Monitoring System Max, GE Blood Glucose Monitoring System Max Plus
K173638 · Bionime Corporation · Aug 2018
FORA GTel Blood Glucose Monitoring System
K173505 · Foracare, Inc. · Aug 2018
Rightest Blood Glucose Monitoring System Wiz, Rightest Blood Glucose Monitoring System Wiz Plus
K173139 · Bionime Corporation · Jun 2018
POGO Automatic Blood Glucose Monitoring System
K181316 · Intuity Medical, Inc. · Jun 2018
Dario LC Blood Glucose Monitoring System
K172723 · Labstyle Innovation, Ltd. · Mar 2018
K173511 · ActiveCare TD-4121 Blood Glucose Monitoring System
Download PDF FDA Summary Taidoc Technology Cor…